Trade Summary

Yesterday, Wilterding Mark, serving as Chief Financial Officer at RxSight, Inc. (RXST), sold 7,765 shares at $6.96 per share, for a total transaction value of $54,044.40. Following this transaction, Wilterding Mark now holds 25,049 shares of RXST.

This sale represents a 23.66% decrease in Wilterding Mark's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, September 3, 2026 (accepted Sep 2, 9:35 PM ET), 1 day after the trade was made.

RxSight, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.